Abstract
Non-dipping (nocturnal blood pressure [BP] decrease<10%) is related to accelerated urinary salt excretion (u-NaCl), and increased risk of left ventricular hypertrophy (LVH) and cardiovascular events. We evaluated whether non-dippers exhibit an advanced extracellular matrix fibrosis, in relation to increased u-NaCl, among normotensive subjects. We measured plasma tissue inhibitor of matrix metalloproteinase-1 (TIMP-1), a marker of collagen fibrosis in extracellular matrix, to evaluate the relationship between non-dipping and u-NaCl in 73 normotensive subjects (no antihypertensive medications, clinic BP<140/90 mmHg and/or 24-h ambulatory BP<125/80 mmHg). Non-dippers had a significantly higher percentage of subjects with impaired fasting glucose (IFG) or diabetes mellitus (DM), and had a greater left ventricular mass index (LVMI), plasma TIMP-1 level and u-NaCl than dippers (IFG or DM: 24.0 vs. 6.3%, p=0.029; LVMI: 118±31 vs. 103±26 g/m2, p=0.039; TIMP-1: 168±35 vs. 151±30 pg/mL, p=0.035; u-NaCl: 5.1±1.7 vs. 3.9±1.7 g/12 h, p=0.005). In logistic regression analysis, non-dipping was independently associated with u-NaCl and TIMP-1. u-NaCl was correlated with non-dipping (r=0.35, p=0.003) and serum glucose level (r=0.26, p=0.027). On the other hand, TIMP-1 level was significantly correlated with the presence of IFG or DM (r=0.23, p=0.046), but not with u-NaCl. In conclusion, plasma TIMP-1 level, a measure of cardiovascular fibrosis in extracellular matrix, is greater in normotensive non-dippers than in dippers; however, the increased TIMP-1 level may be related to impaired glucose metabolism, and non-dipping may be related to increased u-NaCl associated with high serum glucose levels in normotensive subjects.
Similar content being viewed by others
Article PDF
References
Sega R, Facchetti R, Bombelli M, et al: Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: Follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005; 111: 1777–1783.
O'Brien E, Sheridan J, O'Malley K : Dippers and non-dippers. Lancet 1988; 2: 397.
Hoshide S, Kario K, Hoshide Y, et al: Associations between nondipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives. Am J Hypertens 2003; 16: 434–438.
Shimada K, Kawamoto A, Matsubayashi K, Nishinaga M, Kimura S, Ozawa T : Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J Hypertens 1992; 10: 875–878.
Bianchi S, Bigazzi R, Baldari G, Sgherri G, Campese VM : Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens 1994; 7: 23–29.
Lurbe E, Redon J, Kesani A, et al: Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 2002; 347: 797–805.
Staessen JA, Thijs L, Fagard R, et al, for the Systolic Hypertension in Europe Trial Investigators: Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999; 282: 539–546.
Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K : Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 2001; 38: 852–857.
Ohkubo T, Hozawa A, Yamaguchi J, et al: Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 2002; 20: 2183–2189.
Opie L, Commerford P, Gersh B, Pfeffer M : Controversies in ventricular remodelling. Lancet 2006; 367: 356–367.
Weber KT : Monitoring vascular sclerosis in hypertension: a new window of opportunity. Circulation 1998; 98: 498–500.
Ishikawa J, Kario K, Matsui Y, et al: Collagen metabolism in extracellular matrix may be involved in arterial stiffness in older hypertensive patients with left ventricular hypertrophy. Hypertens Res 2005; 28: 995–1001.
Laviades C, Varo N, Fernandez J, et al: Abnormalities of the extracellular degradation of collagen type I in essential hypertension. Circulation 1998; 98: 535–540.
Zureik M, Beaudeux JL, Courbon D, Benetos A, Ducimetiere P : Serum tissue inhibitors of metalloproteinases 1 (TIMP-1) and carotid atherosclerosis and aortic arterial stiffness. J Hypertens 2005; 23: 2263–2268.
Sachdeva A, Weder AB : Nocturnal sodium excretion, blood pressure dipping, and sodium sensitivity. Hypertension 2006; 48: 527–533.
Bankir L, Bochud M, Maillard M, Bovet P, Gabriel A, Burnier M : Nighttime blood pressure and nocturnal dipping are associated with daytime urinary sodium excretion in African subjects. Hypertension 2008; 51: 891–898.
Sahn DJ, DeMaria A, Kisslo J, Weyman A : Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072–1083.
Devereux RB, Reichek N : Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613–618.
Okin PM, Devereux RB, Gerdts E, et al, for the LIFE Study Investigators: Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention for Endpoint (LIFE) reduction in hypertension study. Circulation 2006; 113: 1588–1596.
Bella JN, Devereux RB, Roman MJ, et al: Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the Strong Heart Study). Am J Cardiol 2001; 87: 1260–1265.
Asbun J, Villarreal FJ : The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. J Am Coll Cardiol 2006; 47: 693–700.
Eguchi K, Kario K, Hoshide S, Ishikawa J, Morinari M, Shimada K : Type 2 diabetes is associated with left ventricular concentric remodeling in hypertensive patients. Am J Hypertens 2005; 18: 23–29.
Eguchi K, Ishikawa J, Hoshide S, et al: Differential impact of left ventricular mass and relative wall thickness on cardiovascular prognosis in diabetic and nondiabetic hypertensive subjects. Am Heart J 2007; 154: 79.e9–79.e15.
Dollery CM, McEwan JR, Henney AM : Matrix metalloproteinases and cardiovascular disease. Circ Res 1995; 77: 863–868.
Pistrosch F, Reissmannb E, Wildbrettb J, Koehlerc C, Hanefeld M : Relationship between diurnal blood pressure variation and diurnal blood glucose levels in type 2 diabetic patients. Am J Hypertens 2007; 20: 541–545.
Kuroda S, Uzu T, Fujii T, et al: Role of insulin resistance in the genesis of sodium sensitivity in essential hypertension. J Hum Hypertens 1999; 13: 257–262.
Uzu T, Ishikawa K, Fujii T, Nakamura S, Inenaga T, Kimura G : Sodium restriction shifts circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation 1997; 96: 1859–1862.
Uzu T, Takeji M, Yamauchi A, Kimura G : Circadian rhythm and postural change in natriuresis in non-dipper type of essential hypertension. J Hum Hypertens 2001; 15: 323–327.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ishikawa, J., Hoshide, S., Eguchi, K. et al. Plasma Tissue Inhibitor of Matrix Metalloproteinase-1 Level Is Increased in Normotensive Non-Dippers in Association with Impaired Glucose Metabolism. Hypertens Res 31, 2045–2051 (2008). https://doi.org/10.1291/hypres.31.2045
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1291/hypres.31.2045